Mayank Bhandari - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Mayank Bhandari's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists todayMayank Bhandari
Verified
Founder, Voyage LA
Los Angeles
Beats
disinformation, corruption Ukraine, and anything else worth investigating. extremism,Politics AI, Russia
Content
By Mayank Bhandari, Amelia N. Chang, Thomas Devenyns, Alex Devereson| McKinsey & Company Verified Novel modalities carry huge potential. 1 Within oncology, for example, cell therapy is expected to become the third-largest segment across all modalities (behind antibodies and small molecules) by 2030, with 35 percent CAGR in sales over 2021–30 (Exhibit 1). Gene- and RNA-based therapies, on the other hand, are unlikely to play a major role in the short to medium term, although there are currently more than one hundred such assets in Phase I–III studies.
By Mayank Bhandari, Amelia N. Chang, Thomas Devenyns, Alex Devereson| McKinsey & Company Verified Novel modalities carry huge potential. 1 Within oncology, for example, cell therapy is expected to become the third-largest segment across all modalities (behind antibodies and small molecules) by 2030, with 35 percent CAGR in sales over 2021–30 (Exhibit 1). Gene- and RNA-based therapies, on the other hand, are unlikely to play a major role in the short to medium term, although there are currently more than one hundred such assets in Phase I–III studies.
Company Info
Voyage LA
Los Angeles, United States
Founded: 2017